Ernexa Therapeutics Inc (ERNA) insider trading

Every open-market stock purchase and sale by Ernexa Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $2.7M over the last 12 months (1 buy).
  • Last insider buy: Charles Cherington (10% owner), $2.7M, 8 months ago.

Last 12 months: insiders bought $2.7M (1 buy) and sold $0 (0 sales). Last close $2.08 on Oct 22, 2026.

Recent ERNA insider trades

DateInsiderTradeValue
Aug 31, 2026Peter Cicala (Director)Bought (not open market)—
Aug 31, 2026Elena Ratner (Director)Bought (not open market)—
Aug 31, 2026David Polinsky (Director)Bought (not open market)—
Aug 31, 2026James Arthur Bristol (Director)Bought (not open market)—
Aug 31, 2026James Arthur Bristol (Director)Bought (not open market)—
Aug 31, 2026Peter Cicala (Director)Bought (not open market)—
Aug 31, 2026William A. Wexler (Director)Bought (not open market)—
Aug 31, 2026Sanjeev Luther (CEO)Bought (not open market)—
Feb 10, 2026Charles Cherington (10% owner)Bought$2.7M

Who's trading ERNA

Get free alerts when an insider at Ernexa Therapeutics Inc files a new trade →